Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation
- 1 January 2016
- book chapter
- Published by Elsevier
- Vol. 130, 55-111
Abstract
No abstract availableKeywords
This publication has 243 references indexed in Scilit:
- Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagyCancer, 2011
- Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cellsAmino Acids, 2011
- Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cellsBreast Cancer Research and Treatment, 2011
- Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancerMolecular Carcinogenesis, 2011
- Phase 1b‐2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum‐resistant or platinum‐refractory epithelial ovarian cancerCancer, 2010
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancerCancer, 2010
- Oxidation of amines by flavoproteinsArchives of Biochemistry and Biophysics, 2010
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabineInternational Journal of Cancer, 2008
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992